Kazumichi Kuroda Selected Research

Kazumichi Kuroda Research Topics

Disease

7	Infections 01/2020 - 06/2003
4	Virus Diseases (Viral Diseases) 01/2018 - 06/2003
3	Human Influenza (Influenza) 08/2018 - 03/2009
3	Inflammation (Inflammations) 09/2017 - 06/2012
2	Neoplasms (Cancer) 08/2020 - 02/2008
2	Hepatocellular Carcinoma (Hepatoma) 05/2020 - 05/2017
2	Non-alcoholic Fatty Liver Disease 01/2019 - 07/2018
2	Rheumatoid Arthritis 09/2017 - 12/2005
1	Seasonal Allergic Rhinitis (Hay Fever) 08/2021
1	Adenocarcinoma 08/2020
1	Pancreatic Neoplasms (Pancreatic Cancer) 08/2020
1	Obesity 01/2019
1	Pneumonia (Pneumonitis) 08/2018
1	Fibrosis (Cirrhosis) 07/2018
1	Intellectual Disability (Idiocy) 03/2018
1	Osteoarthritis 09/2017
1	Chronic Urticaria 09/2014
1	Communicable Diseases (Infectious Diseases) 04/2013
1	Stroke (Strokes) 06/2012
1	Infarction (Infarctions) 06/2012
1	Leukemia 03/2009
1	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 02/2008
1	Persistent Infection 02/2007
1	Lymphoma (Lymphomas) 02/2007
1	T-Cell Lymphoma (Lymphoma, T Cell) 02/2007
1	Hepatitis E 02/2007
1	Hepatitis 02/2007
1	Chronic Hepatitis C 01/2005
1	Coinfection 06/2003
1	Body Weight (Weight, Body) 06/2003

Drug/Important Bio-Agent (IBA)

7	Proteins (Proteins, Gene)FDA Link 01/2019 - 11/2007
3	RNA (Ribonucleic Acid)IBA 08/2020 - 01/2005
3	CytokinesIBA 07/2018 - 12/2005
3	AntibodiesIBA 06/2012 - 06/2003
2	Pharmaceutical PreparationsIBA 08/2021 - 01/2012
2	Toll-Like Receptors (Toll-Like Receptor)IBA 08/2020 - 05/2020
2	InterferonsIBA 08/2020 - 12/2004
2	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 12/2004
2	Substance PIBA 09/2017 - 09/2014
2	Biomarkers (Surrogate Marker)IBA 09/2015 - 02/2007
1	Poly I-CIBA 08/2020
1	regorafenibIBA 05/2020
1	Phosphotransferases (Kinase)IBA 05/2020
1	lenvatinibIBA 05/2020
1	ArrestinIBA 01/2019
1	PowdersIBA 08/2018
1	CaspasesIBA 07/2018
1	JNK Mitogen-Activated Protein KinasesIBA 07/2018
1	InflammasomesIBA 07/2018
1	beta-Lactamases (beta-Lactamase)IBA 03/2018
1	Viral ProteinsIBA 01/2018
1	TachykininsIBA 09/2017
1	Protein Glutamine gamma Glutamyltransferase 2IBA 05/2017
1	VaccinesIBA 01/2015
1	Vasoactive Intestinal Peptide (VIP (Vasoactive Intestinal Peptide))IBA 09/2014
1	NeuropeptidesIBA 09/2014
1	Therapeutic UsesIBA 04/2013
1	PolyphenolsIBA 04/2013
1	PeroxiredoxinsIBA 06/2012
1	OligosaccharidesIBA 01/2012
1	Zanamivir (Relenza)FDA Link 01/2012
1	Neuraminidase (Sialidase)IBA 01/2012
1	N-Acetylneuraminic Acid (Sialic Acid)IBA 01/2012
1	Methanol (Carbinol)IBA 03/2009
1	Staphylococcal Protein A (Protein A)IBA 03/2009
1	Membrane Proteins (Integral Membrane Proteins)IBA 02/2008
1	Oncogene Proteins (Oncogene Protein)IBA 02/2008
1	NucleolinIBA 11/2007
1	Viral RNAIBA 02/2007
1	Interleukin-1 (Interleukin 1)IBA 12/2005
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2005
1	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 12/2005
1	Antiviral Agents (Antivirals)IBA 12/2004
1	2',5'-Oligoadenylate Synthetase (2',5' Oligoadenylate Synthetase)IBA 12/2004
1	Messenger RNA (mRNA)IBA 12/2004
1	Interferon-alpha (Interferon Alfa)IBA 12/2004
1	Immunoglobulin G (IgG)IBA 06/2003
1	Cytidine DeaminaseIBA 06/2003
1	Neutralizing AntibodiesIBA 06/2003
1	Immunoglobulin M (IgM)IBA 06/2003
1	Immunoglobulins (Immunoglobulin)IBA 06/2003
1	Monoclonal AntibodiesIBA 06/2003

Therapy/Procedure

1	Intranasal Administration 08/2018
1	Long-Term Care 03/2018
1	Lasers (Laser) 11/2007
1	Blood Transfusion (Blood Transfusions) 02/2007
1	Drug Therapy (Chemotherapy) 02/2007
1	Blood Component Removal (Apheresis) 01/2005